Therapeutic Value of Orphan Drugs Approved by Health Canada: A Cross-Sectional Study
Author:
Publisher
Springer Science and Business Media LLC
Link
https://link.springer.com/content/pdf/10.1007/s11606-024-08651-8.pdf
Reference7 articles.
1. Health Canada. Health products highlights 2021: helping you maintain and improve your health. Ottawa 2022 [updated August. Available from: https://www.canada.ca/content/dam/hc-sc/documents/services/publications/drugs-health-products/health-product-highlights-2021/health-product-highlights-2021-en.pdf.
2. Patented Medicine Prices Review Board. Annual report 2021. Ottawa; 2022.
3. Lexchin J. Quality and quantity of data used by Health Canada in approving new drugs. Frontiers in Medicine. 2023;10:1299239.
4. Lexchin J. Prediction of therapeutic value of new drugs approved by Health Canada from 2011-2020: a cross-sectional study. Journal of the Royal Society of Medicine Open. 2023;14(5).
5. Chen E, Haslam A, Prasad V. FDA acceptance of surrogate end points for cancer drug approval. JAMA Internal Medicine. 2020;180(6):912-4.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3